Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : JNJ-Super company, Super stock! -- Ignore unavailable to you. Want to Upgrade?

To: NY0001 who wrote (238)	6/12/1999 1:30:00 PM
From: Anthony Wong	Respond to of 552

"If you want to buy one stock that will give you the broadest breath of mostly everything there is in the pharmaceutical, consumer health, and medical technology area, Johnson & Johnson (JNJ 89 1/2) is the stock for all seasons," says David. They have one of the broadest diversifications in health care, along with accelerating earnings and over $25 billion in annual sales. SI Newsletter: Pharmaceutical & Biotech Outlook with David Saks of Gruntal & Company techstocks.com

To: NY0001 who wrote (238)	7/19/1999 4:22:00 PM
From: NY0001	Read Replies (2) \| Respond to of 552

Benecol Selling Well in the US. Friday July 16, 6:36 am Eastern Time Raisio says pleased if Benecol U.S. data accurate HELSINKI, July 16 (Reuters) - Finnish food group Raisio said on Friday it was pleased if reports about the market share of its Benecol products in the United States were accurate, but it could not confirm the figures. Merrill Lynch analyst Bram Cornelisse told Reuters that based on independently collected data he had obtained, he believed Benecol had a 2.4 percent share of the U.S. margarine market versus a 0.5 percent share for rival Unilever's Take Control. ''I have not seen the official data, so I can only say that if it is correct we are really pleased,'' Raisio spokesman Sten von Hellens said. The data was for a four-week period starting in late May after cholesterol-cutting Benecol margarines and spreads were launched, Cornelisse said. Benecol is marketed in the United States and internationally by Johnson and Johnson unit McNeil Consumer Products (NYSE:JNJ - news). Cornelisse cautioned, however, that as Unilever had so far conducted no marketing campaign for Take Control he expected its market share to rise. A Unilever spokesman told Reuters late on Thursday that the company was about to start such a campaign. Raisio's share has rocketed on talk of Benecol's U.S. market share, rising 7.4 percent on Thursday and 12.2 percent on Friday to trade at 12.05 euros at 1028 GMT, making it Europe's top gainer . The share has gained almost 130 percent since it hit a low of 5.30 euros in February as investors were cheered by Benecol products being launched in the United States and Europe. But the stock still has a way to climb to peaks of 18 euros reached in May 1998.